| Literature DB >> 26395179 |
Xiaoqin Wang1,2,3,4, Yaolong Chen5,6,7, Nan Yang8, Wei Deng9, Qi Wang10,11,12, Nan Li13, Liang Yao14,15,16, Dang Wei17,18,19, Gen Chen20,21, Kehu Yang22,23,24.
Abstract
BACKGROUND: With increasing attention put on the methodology of reporting guidelines, Moher et al. conducted a review of reporting guidelines up to December 2009. Information gaps appeared on many aspects. Therefore, in 2010, the Guidance for Developers of Health Research Reporting Guidelines was developed. With more than four years passed and a considerable investment was put into reporting guideline development, a large number of new, updated, and expanded reporting guidelines have become available since January 2010. We aimed to systematically review the reporting guidelines published since January 2010, and investigate the application of the Guidance.Entities:
Mesh:
Year: 2015 PMID: 26395179 PMCID: PMC4579604 DOI: 10.1186/s12874-015-0069-z
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Fig. 1Flow chart of reporting guidelines identified, included and excluded. A total of 4329 records were hit by searching electronic databases. After 1387 duplicates removed, 2942 records were screened trough titles and abstracts, and 2877 were excluded. Then 65 full text articles assessed for eligibility, in which 37 were excluded. At last, together with 32 additional reporting guidelines from EQUATOR, 60 reporting guidelines were included
Basic information of included reporting guidelines
| Items | Option | Number (%) |
|---|---|---|
| Short name | Provided | 30 (50) |
| Specific website | Provided | 14 (23) |
| Year of publication | 2010 | 16 (28) |
| 2011 | 14 (23) | |
| 2012 | 13 (22) | |
| 2013 | 15 (25) | |
| 2014 | 2 (3) | |
| Development duration (year) | 2 | 1 (2) |
| 3 | 1 (2) | |
| Not provided | 58 (96) | |
| Language of publication | English | 60 (100) |
| Specific group | Provided | 23 (38) |
| Information of develop members | Provided | 59 (98) |
| Reference list | Provided | 60 (100) |
Characteristics of reporting guidelines
| Items | Items | Number (%) |
|---|---|---|
| Study type(s) to be reporteda | Study design not specified | 20 (33) |
| Randomized controlled trials | 9 (15) | |
| Laboratory/preclinical studies | 5 (8) | |
| Prospective clinical trials | 2 (3) | |
| Observational studyb | 11 (18) | |
| Economic evaluation | 3 (5) | |
| Systematic review/meta-analysis/HTAc | 5 (8) | |
| Qualitative research | 2 (3) | |
| Cross-sectional studies | 2 (3) | |
| Other specific design or types specified (diagnostic accuracy studies, quality improvement research, Realist syntheses, clinical practice guideline, Systematic review/meta-analysis/HTA) | 12 (20) | |
| Methods for initial itemsd | Literature review | 25 (42) |
| Refer to existing reporting guidelines | 20 (33) | |
| Opinions of experts or consensus of experts | 16 (27) | |
| Consensus methodse | ||
| Formal | Delphi | 13 (22) |
| Nominal group technique | 3 (5) | |
| Consensus meeting | 21 (35) | |
| Informal | Questionnaire grade | 1 (2) |
| Circulating several versions of the statement within the group of developers and an external circle of potential users. | 2 (3) | |
| Web-based survey rating the importance of each of the checklist items | 1 (2) | |
| Terminated after fixed round(s) of Delphi | 1 | 2 (3) |
| 2 | 5 (8) | |
| 3 | 4 (7) | |
| Stakeholders in the consensus process | Content experts | 25 (42) |
| Epidemiologists | 7 (12) | |
| Journal editors | 14 (23) | |
| Methodologists | 19 (32) | |
| Othersf | 14 (23) | |
| Funding | Yes | 36 (60) |
| No | 4 (7) | |
| Unclear | 20 (33) | |
| COI | Yes | 14 (23) |
| No | 28 (47) | |
| Unclear | 18 (30) |
aSome reporting guidelines are designed for more than one type of research
bIncluding various kinds of observational studies, such as case report, cohort study, case–control study cross-sectional study
cHTA: Health technology assessment
dSome reporting guidelines used two or more methods to generate initial items
eSome reporting guidelines used two methods
fIncluding clinicians, funders, students, government agencies, professional organizations, publishers and patients
Fig. 2The information of core items in reporting guidelines
Fig. 3Comparison of guidelines that mentioned the Guidance vs those that did not